Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
NCT03685747Phase 1Completed
- Sponsor
- Thomas Jefferson University
- Start
- Nov 2018
- Primary completion
- Aug 2020
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vancomycin in peritonitis, sponsored by Thomas Jefferson University. Primary endpoints: Maximum Total Plasma Concentration at Day 1, Time to Maximum Plasma Concentration at Day 1 and 3 more. Started Nov 2018; status: completed.
02
Drugs
vancomycin
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT03685747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685747.